Showing results (41-50 of 88) with videos related to
Sort By:
Pageof 9
CEN Case Reports|January 19, 2026
Repeat kidney biopsy reveals new-onset IgA nephropathy in a patient with ANCA-associated vasculitisSeina Iwami, Masahiro Eriguchi, Takaaki Kosugi, et al.Kidney360|June 19, 2025
Effects of SGLT2 Inhibitors on Lower eGFR Decline in Non-Diabetic CKD Patients without ProteinuriaMasaru Matsui, Takaaki Kosugi, Kosuke Tansho, et al.Scientific Reports|January 1, 2020
Inflammation as a predictor of acute kidney injury and mediator of higher mortality after acute kidney injury in non-cardiac surgeryMiho Murashima, Masatoshi Nishimoto, Maiko Kokubu, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2006
Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitisLiping Liu, Deren Huang, Masaru Matsui, et al.BMJ Open Diabetes Research & Care|November 5, 2020
Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathySadanori Okada, Ken-Ichi Samejima, Masaru Matsui, et al.Journal of Neuroimmunology|July 6, 2002
Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTESMasaru Matsui, Jennifer Weaver, Amanda E I Proudfoot, et al.Case Reports in Nephrology|September 9, 2014
Therapeutic Benefits of Tocilizumab Vary in Different Organs of a Patient with AA AmyloidosisMasaru Matsui, Satoshi Okayama, Hideo Tsushima, et al.Clinical and Experimental Nephrology|August 8, 2021
Association of initial prednisolone dose with remission, relapse, and infectious complications in adult-onset minimal change diseaseKaori Tanabe, Ken-Ichi Samejima, Fumihiro Fukata, et al.BMC Nephrology|November 25, 2025
Design and rationale for a pilot trial of D-alanine supplementation to reduce the triglyceride to high-density lipoprotein cholesterol ratio in patients with chronic kidney diseaseMasaru Matsui, Masatoshi Nishimoto, Takayuki Uemura, et al.Diabetes, Obesity & Metabolism|November 3, 2023
Utility of serum β2-microglobulin for prediction of kidney outcome among patients with biopsy-proven diabetic nephropathyTakayuki Uemura, Masatoshi Nishimoto, Masahiro Eriguchi, et al.Pageof 9